牛叉诊股

[{"date":"2025.11.19","stock":"-0.93","trade":"-1.90","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.25","trade":"-0.92","ind":"-0.92"},{"date":"2025.11.17","stock":"-0.43","trade":"-2.18","ind":"-0.11"},{"date":"2025.11.14","stock":"-0.12","trade":"0.63","ind":"-1.93"},{"date":"2025.11.13","stock":"1.05","trade":"1.09","ind":"1.78"},{"date":"2025.11.12","stock":"-0.25","trade":"0.87","ind":"-0.36"},{"date":"2025.11.11","stock":"0.31","trade":"0.43","ind":"-1.03"},{"date":"2025.11.10","stock":"0.56","trade":"1.72","ind":"0.18"},{"date":"2025.11.07","stock":"1.84","trade":"-0.48","ind":"-0.36"},{"date":"2025.11.06","stock":"0.00","trade":"-0.33","ind":"1.73"},{"date":"2025.11.05","stock":"0.38","trade":"-0.81","ind":"0.37"},{"date":"2025.11.04","stock":"0.26","trade":"-0.81","ind":"-1.71"},{"date":"2025.11.03","stock":"-0.51","trade":"0.04","ind":"0.19"},{"date":"2025.10.31","stock":"0.90","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.83","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"-2.30","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"0.06","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"-1.71","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"0.06","trade":"0.39","ind":"2.02"},{"date":"2025.10.23","stock":"0.62","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"0.12","trade":"-0.28","ind":"-0.62"}]

派林生物,深证成指,生物制品指数

压力支撑

该股压力位为16.12元，支撑位为16.00元。

[{"text":"\u538b\u529b\u4f4d","value":"16.12","date":1763481600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"16.00","date":1763481600,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.9资金面打败了63%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：11月19日 18:06

机构今日流向(万元)	-1803.39	机构5日流向(万元)	-7355.00
机构10日流向(万元)	-10766.45	机构20日流向(万元)	-14685.64

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加12462.90万股，其中基金净增仓34家，主力净减仓49家，请投资者中长期谨慎为宜。

截止2025-06-30，共220家主力机构（基金212家，一般法人7家，社保基金1家），持仓量总计51984.18万股，占流通A股55.26%
其中，基金持仓与2024-12-31相比：
增仓：73家，增持 1136.50万股
减仓：39家，减持 2460.64万股
新出现在主力名单中：95家，持有5723.62万股
从主力名单中消失：144家，原持有4275.21万股

消息面诊股

诊断结果：5.5消息面打败了3%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2025-10-29
一般消息	募资投向		2025-10-28
一般消息	资产重组	公司股权转让	2025-09-10
一般消息	分红转增	不分配不转增	2025-08-22
利空	重大事项	公司违规：处罚类型	2025-05-12
利好	分红转增	10转3股派3.5元(含税)	2025-04-24

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	0条	1条

行业面诊股

诊断结果：6.4行业面打败了81%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.11.19","price":"-0.00","value":"-1.90"},{"date":"2025.11.18","price":"-0.92","value":"-0.92"},{"date":"2025.11.17","price":"-0.11","value":"-2.18"},{"date":"2025.11.14","price":"-1.93","value":"0.63"},{"date":"2025.11.13","price":"1.78","value":"1.09"},{"date":"2025.11.12","price":"-0.36","value":"0.87"},{"date":"2025.11.11","price":"-1.03","value":"0.43"},{"date":"2025.11.10","price":"0.18","value":"1.72"},{"date":"2025.11.07","price":"-0.36","value":"-0.48"},{"date":"2025.11.06","price":"1.73","value":"-0.33"},{"date":"2025.11.05","price":"0.37","value":"-0.81"},{"date":"2025.11.04","price":"-1.71","value":"-0.81"},{"date":"2025.11.03","price":"0.19","value":"0.04"},{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.62","value":"-0.28"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	*ST四环	126.72%	1.15%	6.1分
2	博晖创新	32.23%	5.42%	5.5分
3	万泽股份	28.01%	-5.40%	6.5分
4	康华生物	11.11%	-0.36%	6.0分
5	三生国健	10.96%	-3.50%	5.4分
6	ST未名	8.01%	-2.06%	5.4分
7	-	7.46%	-14.81%	分
8	华兰疫苗	6.84%	-1.85%	5.0分
9	沃森生物	6.73%	-2.37%	5.0分
10	*ST双成	6.49%	0.50%	4.7分
11	诺诚健华	4.63%	-3.86%	6.2分
12	优宁维	4.48%	-1.57%	6.1分
13	诺唯赞	4.39%	-2.55%	6.2分
14	智飞生物	3.07%	-3.61%	4.9分
15	辽宁成大	2.22%	-2.89%	5.3分
16	昊帆生物	2.12%	-5.88%	5.5分
17	赛伦生物	1.84%	-2.98%	5.6分
18	安科生物	1.66%	-6.21%	5.3分
19	赛升药业	1.31%	-3.57%	4.9分
20	康泰生物	1.14%	-3.56%	5.3分
21	卫光生物	0.96%	-3.61%	5.8分
22	东宝生物	0.69%	-1.52%	6.3分
23	特宝生物	0.61%	-0.54%	6.5分
24	通化东宝	0.34%	-4.55%	5.3分
25	上海莱士	-0.15%	-3.32%	5.6分
26	-	-0.15%	-8.50%	分
27	我武生物	-0.19%	-2.86%	5.1分
28	义翘神州	-0.54%	-5.61%	5.0分
29	博雅生物	-0.65%	-3.61%	5.4分
30	百克生物	-0.67%	-3.55%	5.8分
31	百普赛斯	-1.34%	-5.09%	5.0分
32	派林生物	-1.35%	-0.68%	6.2分
33	艾迪药业	-1.56%	-3.39%	5.9分
34	欧林生物	-2.63%	-4.49%	6.4分
35	智翔金泰	-2.78%	-4.74%	4.6分
36	-	-3.13%	-3.53%	分
37	华兰生物	-3.46%	-5.07%	5.2分
38	君实生物	-3.97%	-3.34%	5.2分
39	西藏药业	-4.94%	-3.32%	5.9分
40	康希诺	-5.13%	-5.31%	5.1分
41	凯因科技	-5.29%	-6.62%	5.0分
42	天坛生物	-5.44%	-2.43%	5.3分
43	百奥泰	-5.92%	-3.92%	5.3分
44	迈威生物	-6.49%	-4.59%	4.7分
45	康弘药业	-7.39%	-2.90%	5.8分
46	荣昌生物	-7.82%	1.81%	5.6分
47	神州细胞	-8.46%	-3.77%	5.3分
48	甘李药业	-9.94%	-4.00%	5.2分
49	康辰药业	-10.61%	-3.97%	5.6分
50	科兴制药	-11.16%	-11.96%	5.4分
51	长春高新	-14.10%	-1.08%	5.4分
52	金迪克	-57.37%	0.00%	5.6分
53	成大生物	-64.20%	-2.32%	5.3分
54	禾元生物	-	-11.43%	3.6分
55	近岸蛋白	-	-2.76%	4.5分

<上一页 1 2 3 4 5...10 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.3基本面打败了63%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（57.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 23/72 ， 41/72。

[{"date":"2025-09-30","value":"4.48","vol":"-9.78"},{"date":"2025-06-30","value":"2.98","vol":"-0.61"},{"date":"2025-03-31","value":"1.12","vol":"0.46"},{"date":"2024-12-31","value":"9.71","vol":"-0.68"},{"date":"2024-09-30","value":"7.11","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	4.48	2.98	1.12	9.71	7.11
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"46.32","vol":"67.61"},{"date":"2025-06-30","value":"47.63","vol":"68.28"},{"date":"2025-03-31","value":"48.06","vol":"68.43"},{"date":"2024-12-31","value":"49.13","vol":"69.85"},{"date":"2024-09-30","value":"50.52","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	46.32	47.63	48.06	49.13	50.52
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 43/72 ， 37/72。

[{"date":"2025-09-30","value":"-14.40","vol":"45.25"},{"date":"2025-06-30","value":"-13.18","vol":"6902.04"},{"date":"2025-03-31","value":"-14.00","vol":"6125.27"},{"date":"2024-12-31","value":"14.00","vol":"47.35"},{"date":"2024-09-30","value":"37.49","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-14.40	-13.18	-14.00	14.00	37.49
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-34.19","vol":"44.80"},{"date":"2025-06-30","value":"-27.89","vol":"5.44"},{"date":"2025-03-31","value":"-26.95","vol":"-8.46"},{"date":"2024-12-31","value":"21.76","vol":"-9.81"},{"date":"2024-09-30","value":"66.38","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-34.19	-27.89	-26.95	21.76	66.38
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 28/72 ， 33/72。

[{"date":"2025-09-30","value":"0.17","vol":"0.22"},{"date":"2025-06-30","value":"0.11","vol":"0.14"},{"date":"2025-03-31","value":"0.04","vol":"0.06"},{"date":"2024-12-31","value":"0.30","vol":"0.29"},{"date":"2024-09-30","value":"0.21","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.17	0.11	0.04	0.30	0.21
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.59","vol":"0.92"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.15","vol":"0.26"},{"date":"2024-12-31","value":"1.26","vol":"1.17"},{"date":"2024-09-30","value":"0.91","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.59	0.36	0.15	1.26	0.91
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"15.23","vol":"1.84"},{"date":"2025-06-30","value":"-12.56","vol":"-1377.61"},{"date":"2025-03-31","value":"-30.92","vol":"-46.99"},{"date":"2024-12-31","value":"12.33","vol":"-11.33"},{"date":"2024-09-30","value":"15.21","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	15.23	-12.56	-30.92	12.33	15.21
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.50","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.83","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	2.50	-	3.83	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 14/72 ， 16/72。

[{"date":"2025-09-30","value":"2.93","vol":"6.00"},{"date":"2025-06-30","value":"3.67","vol":"6.64"},{"date":"2025-03-31","value":"4.19","vol":"7.75"},{"date":"2024-12-31","value":"3.74","vol":"6.72"},{"date":"2024-09-30","value":"4.06","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.93	3.67	4.19	3.74	4.06
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.56","vol":"4.84"},{"date":"2025-06-30","value":"1.87","vol":"5.30"},{"date":"2025-03-31","value":"2.37","vol":"6.35"},{"date":"2024-12-31","value":"2.42","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.56	1.87	2.37	2.42	2.70
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 32/72 ， 32/72。

[{"date":"2025-09-30","value":"16.25","vol":"28.18"},{"date":"2025-06-30","value":"13.04","vol":"26.73"},{"date":"2025-03-31","value":"12.94","vol":"26.03"},{"date":"2024-12-31","value":"14.37","vol":"25.81"},{"date":"2024-09-30","value":"13.57","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	16.25	13.04	12.94	14.37	13.57
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.19","vol":"0.58"},{"date":"2025-06-30","value":"0.15","vol":"1.11"},{"date":"2025-03-31","value":"0.15","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.87"},{"date":"2024-09-30","value":"0.16","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.19	0.15	0.15	0.17	0.16
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国泰海通证券	2025-09-09	买入
中信证券	2025-09-05	买入
东方证券	2025-09-02	买入
野村东方国际证券	2025-08-27	增持

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.09","blueLineValue":"0.85","type":"YC"}]

[派林生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]